| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 6, 2024 | SHC Sotera Health Co | Warburg Pincus & Co.67 | Director, 10% Owner | Sell | 15,000,000 | $15.03 | $225,450,000.00 | -16.9% | -17.1% | -0.2% | |
| Sep 6, 2024 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 912 | $39.16 | $35,714.83 | -1.0% | +38.2% | -29.8% | |
| Sep 6, 2024 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 2,340 | $39.16 | $91,636.74 | -0.5% | +38.2% | -29.8% | |
| Sep 6, 2024 | TWST Twist Bioscience Corp | Werner Robert F.62 | Chief Accounting Officer | Sell | 240 | $39.16 | $9,398.64 | -0.6% | +38.2% | -29.8% | |
| Sep 5, 2024 | CSTL Castle Biosciences Inc | Bradbury Daniel69 | Director | Sell | 7,867 | $29.02 | $228,331.81 | -16.7% | +8.1% | -20.1% | |
| Sep 4, 2024 | VCYT Veracyte, Inc. | Leite John49 | Chief Commercial Officer-clia | Sell | 5,479 | $29.78 | $163,159.14 | -6.7% | +47.7% | +6.7% | |
| Sep 4, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 1,914 | $30.04 | $57,492.72 | -0.3% | +6.5% | -20.1% | |
| Sep 4, 2024 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 20,000 | $608.45 | $12,168,973.87 | -0.8% | -12.7% | -20.0% | |
| Sep 4, 2024 | BIO Bio-Rad Laboratories, Inc. | Barry James | EVP, President, Lsg | Sell | 623 | $330.49 | $205,898.14 | -81.0% | +0.4% | -12.5% | |
| Sep 3, 2024 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 1,503 | $21.96 | $33,007.38 | -0.2% | -10.4% | +0.8% | |
| Sep 3, 2024 | CSTL Castle Biosciences Inc | Oelschlager Kristen M72 | Chief Operating Officer | Sell | 5,832 | $29.21 | $170,330.09 | -2.1% | +7.6% | -20.5% | |
| Sep 3, 2024 | MYGN Myriad Genetics Inc | Reitan Colleen F69 | Director | Sell | 46,012 | $27.95 | $1,285,851.35 | -52.0% | -39.2% | -75.2% | |
| Sep 3, 2024 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 1,594 | $21.96 | $35,005.83 | -0.5% | -10.4% | +0.8% | |
| Sep 3, 2024 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 1,674 | $21.96 | $36,762.71 | -0.8% | -10.4% | +0.8% | |
| Sep 3, 2024 | WGS Genedx Holdings Corp. | Feeley Kevin46 | Chief Financial Officer | Sell | 262 | $31.71 | $8,307.92 | -0.7% | +151.4% | +314.0% | |
| Aug 30, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 4,441 | $30.08 | $133,583.74 | -0.8% | +2.1% | -19.1% | |
| Aug 27, 2024 | FLGT Fulgent Genetics, Inc. | Xie Jian77 | President And COO | Sell | 715 | $22.83 | $16,325.60 | -0.2% | -19.9% | -5.4% | |
| Aug 27, 2024 | FLGT Fulgent Genetics, Inc. | Hsieh Ming | Chief Executive Officer | Sell | 2,313 | $22.83 | $52,812.73 | -0.3% | -19.9% | -5.4% | |
| Aug 27, 2024 | FLGT Fulgent Genetics, Inc. | Gao Hanlin73 | Chief Scientific Officer | Sell | 563 | $22.83 | $12,854.98 | - | -19.9% | -5.4% | |
| Aug 27, 2024 | FLGT Fulgent Genetics, Inc. | Kim Paul77 | CFO And Treasurer | Sell | 733 | $22.83 | $16,736.59 | -0.3% | -19.9% | -5.4% | |
| Aug 27, 2024 | IQV Iqvia Holdings Inc. | Sherbet Eric57 | See Remarks | Sell | 1,300 | $246.33 | $320,229.00 | -6.2% | -17.9% | -24.1% | |
| Aug 26, 2024 | DHR Danaher Corp /de/ | Couchara Georgeann56 | SVP, Human Resources | Sell | 952 | $268.37 | $255,483.48 | -18.4% | -11.3% | -23.1% | |
| Aug 26, 2024 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 2,987 | $30.09 | $89,867.68 | -0.5% | +2.3% | -26.0% | |
| Aug 23, 2024 | TWST Twist Bioscience Corp | Werner Robert F.62 | Chief Accounting Officer | Sell | 813 | $43.14 | $35,074.45 | -2.0% | -4.6% | -34.5% | |
| Aug 23, 2024 | MEDP Medpace Holdings, Inc. | Kraft Robert O.51 | Director | Sell | 8,127 | $390.73 | $3,175,462.71 | -88.7% | -12.6% | +18.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.